SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-011893
Filing Date
2020-05-13
Accepted
2020-05-12 21:46:47
Documents
57
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0320_artaratherap.htm 10-Q 605804
2 SECOND CERTIFICATE OF AMENDMENT TO THE SIXTH AMENDED AND RESTATED CERTIFICATE OF f10q0320ex3-3_artara.htm EX-3.3 5592
3 CERTIFICATE OF ELIMINATION OF SERIES A CONVERTIBLE PREFERRED STOCK OF ARTARA THE f10q0320ex3-6_artara.htm EX-3.6 8857
4 CERTIFICATION f10q0320ex31-1_artara.htm EX-31.1 13653
5 CERTIFICATION f10q0320ex31-2_artara.htm EX-31.2 13452
6 CERTIFICATION f10q0320ex32-1_artara.htm EX-32.1 8329
  Complete submission text file 0001213900-20-011893.txt   3090229

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE tara-20200331.xml EX-101.INS 457946
8 XBRL SCHEMA FILE tara-20200331.xsd EX-101.SCH 43414
9 XBRL CALCULATION FILE tara-20200331_cal.xml EX-101.CAL 44105
10 XBRL DEFINITION FILE tara-20200331_def.xml EX-101.DEF 127376
11 XBRL LABEL FILE tara-20200331_lab.xml EX-101.LAB 266456
12 XBRL PRESENTATION FILE tara-20200331_pre.xml EX-101.PRE 215611
Mailing Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36694 | Film No.: 20870858
SIC: 2836 Biological Products, (No Diagnostic Substances)